Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Fernando B. de Moura"'
Autor:
Sarah L. Withey, Lei Cao, Fernando B. de Moura, Kenroy R. Cayetano, Michael L. Rohan, Jack Bergman, Stephen J. Kohut
Publikováno v:
Brain Imaging and Behavior. 16:1684-1694
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee00d6b7b9d192577ef44e3bbf57b846
https://doi.org/10.1007/s11682-022-00639-4
https://doi.org/10.1007/s11682-022-00639-4
Publikováno v:
bioRxiv
The use of non-drug alternative reinforcers has long been utilized as a component of therapeutic interventions for the management of substance use disorder; however, the conditions under which alternative reinforcers are most effective are not well c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134025b2aca026174855ab6b57e2a74a
https://europepmc.org/articles/PMC9882129/
https://europepmc.org/articles/PMC9882129/
Autor:
Fernando B. de Moura, Jack Bergman
Publikováno v:
J Pharmacol Exp Ther
Nicotine has previously been shown to augment the antinociceptive effects of μ-opioid agonists in squirrel monkeys without producing a concomitant increase in behavioral disruption. The present studies were conducted to extend these findings by dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b65713309dcefbf2e67e5f4e1ef2758f
https://doi.org/10.1124/jpet.120.000423
https://doi.org/10.1124/jpet.120.000423
Autor:
Sarah L, Withey, Lei, Cao, Fernando B, de Moura, Kenroy R, Cayetano, Michael L, Rohan, Jack, Bergman, Stephen J, Kohut
Publikováno v:
Brain imaging and behavior. 16(4)
Functional magnetic resonance imaging (fMRI) has been used to study the influence of opioids on neural circuitry implicated in opioid use disorder, such as the cortico-striatal-thalamo-cortical (CSTC) circuit. Given the increase in fentanyl-related d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cd533fb23021771b727605f71853a282
https://pubmed.ncbi.nlm.nih.gov/35226333
https://pubmed.ncbi.nlm.nih.gov/35226333
Publikováno v:
Behav Pharmacol
The α4β2* nicotinic acetylcholine receptor (nAChR) subtypes are targeted for the development of smoking cessation aids, and the use of drug discrimination in mice provides a robust screening tool for the identification of drugs acting through nAChR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0a60a5980d50b44b5b961f7c02d55f
https://europepmc.org/articles/PMC7415560/
https://europepmc.org/articles/PMC7415560/
Autor:
F. Ivy Carroll, Bruce E. Blough, Fernando B. de Moura, Stephen J. Kohut, Claire E. Barkin, Nancy K. Mello
Publikováno v:
Exp Clin Psychopharmacol
Chronic health problems associated with long-term nicotine use are the leading cause of preventable death in the United States. The use of tobacco products is 3-4 times greater among individuals with cocaine use disorder than that observed in the gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59cff6c5133976541745d575f1cdc16
https://pubmed.ncbi.nlm.nih.gov/31789555
https://pubmed.ncbi.nlm.nih.gov/31789555
Publikováno v:
J Pharmacol Exp Ther
Nicotine can produce antinociception in preclinical pain models; however, the ability of nicotine to augment the antinociceptive effects of opioid agonists has not been investigated. The present experiments were conducted to determine how nicotine mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d94112e267c1edfe398cc5e90cf7c88
https://europepmc.org/articles/PMC6863460/
https://europepmc.org/articles/PMC6863460/
Publikováno v:
Brain and Behavior
Brain and Behavior, Vol 10, Iss 4, Pp n/a-n/a (2020)
Brain and Behavior, Vol 10, Iss 4, Pp n/a-n/a (2020)
Objectives There is a long‐standing interest in developing nicotinic acetylcholine receptor (nAChR) antagonists for concomitant use with nAChR agonists (e.g., nicotine replacement) as complementary smoking cessation aids. Previous studies demonstra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee9ca683a9626be05771123f9bb2506b
https://pubmed.ncbi.nlm.nih.gov/32092237
https://pubmed.ncbi.nlm.nih.gov/32092237
Publikováno v:
Advances in pharmacology (San Diego, Calif.). 86
Despite decades of research, few medications have gained Food and Drug Administration (FDA) approval for the management of substance abuse disorder. The paucity of successful medications can be attributed, in part, to the lack of clearly identified n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::518792119797560b43e06bba423ab593
https://pubmed.ncbi.nlm.nih.gov/31378252
https://pubmed.ncbi.nlm.nih.gov/31378252